The HEALTH | March-April. 2025

• Regional Emergency Stroke Quick Response( ResQ)

• Prostate Care Centre( Putra Prostate Centre)

• Advanced Geriatric Care( AGILE)

• Putra Zoonotics Since its establishment, the Putra

Prostate Centre has been driven by a vision to become an internationally recognised centre for prostate care. Its mission is to provide the highest standard of evidence-based treatment for all prostate-related conditions, utilising state-of-the-art technology and cuttingedge equipment.

• UPM Urology and HSAAS are positioning themselves as a global leader in prostate health.

• Cutting-edge treatments and minimally invasive procedures are revolutionising prostate care.

• Through partnerships with the NCI, international institutions and experts, the centre is driving advancements in prostate healthcare.

Prostate-related diseases, remarkably benign prostatic enlargement( BPE) and prostate cancer are among the most common health concerns affecting men worldwide.

In Malaysia, the incidence of prostate cancer has been on the rise, making it imperative for healthcare institutions to offer practical, minimally invasive, and precise treatment solutions.

Malaysia’ s ageing population further exacerbates this issue, as prostate diseases predominantly affect older men. With life expectancy increasing and a growing proportion of elderly individuals, the demand for advanced prostate health services is more pressing than ever.

According to the National Cancer Registry, prostate cancer is the third most common cancer among Malaysian men, underscoring the need for improved early detection and treatment strategies.

TARGETTED APPROACH: Dr Vincent performs an MRI-US fusion targeted prostate biopsy, with the results on the right demonstrating precision and accuracy.

Recognising this need, UPM Urology and HSAAS have positioned themselves as a centre of excellence dedicated to improving early detection, advancing treatment modalities, and enhancing patient outcomes.

HSAAS serves as the teaching hospital for Universiti Putra Malaysia( UPM) and is a leading Center for Clinical Excellence, providing advanced treatment, research, and education in four key niche areas:

ADVANCED PROSTATE CARE

The centre offers a range of specialised services tailored to meet the growing needs of patients dealing with prostaterelated issues. These include:

▶ REZUM Therapy: A game-changer for BPH Benign prostatic enlargement( BPE) is a non-cancerous enlargement of the prostate gland that affects a significant number of ageing men, leading to urinary symptoms such as difficulty urinating, frequent urination, and incomplete bladder emptying. The centre offers REZUM Therapy, a minimally invasive procedure that uses controlled doses of water steam to shrink enlarged prostate tissue. Unlike traditional surgical methods, REZUM does not require hospitalisation and has a shorter recovery time. Patients experience significant symptom relief without compromising sexual function, making it an ideal choice for many men with BPE.

▶ Laser Enucleation Surgery for BPH For patients with severe BPE requiring surgical intervention, the Laser Enucleation Surgery provides a highly effective solution. This advanced technique allows for precise removal of excess prostate tissue while minimising bleeding and reducing the risk of complications. Laser enucleation is more effective for larger prostates than conventional TURP( Transurethral Resection of the Prostate).

▶ Prostatic Artery Embolisation( PAE) PAE is another treatment option offered at our centre for men with BPE. This non-surgical procedure, performed by our esteemed interventional radiologists, involves blocking blood flow to the prostate, leading to a reduction in prostate size and symptom relief. PAE is a safe and effective alternative for patients who are not candidates for surgery or prefer a minimally invasive approach with a faster recovery time.

▶ MRI-US Fusion Prostate Biopsy: Enhancing Cancer Detection Early and accurate detection of prostate cancer is crucial in ensuring effective treatment and improved survival rates. Traditional prostate biopsies often rely solely on transrectal ultrasound( TRUS) guidance, which can miss clinically significant tumours, leading to overdiagnosis and overtreatment. To address